Schistosomiasis and Cancer in Egypt: Review

Journal of Advanced Research

Volumn 4, Issue 5, 2013, Pages 461-466

  Khaled, Hussein ^a  

^a CAIRO UNIVERSITY   (Egypt)

Author keywords

Bilharziasis; Bladder cancer; Schistosomiasis; Squamous cell carcinoma

Indexed keywords

EID: 84881670182     PISSN: 20901232     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jare.2013.06.007     Document Type: Review

References (45)

1. Bouvard V., Baan R., Straif K., Grosse Y., Secretan B., El Ghissassi F., et al. A review of human carcinogens - Part B: biological agents. WHO international agency for research on cancer monograph working group. Lancet Oncol 2009, 10:321-322.
2. Nash T.E., Cheever A.W., Ottesen E.A., Cook J.A. Schistosome infections in humans: perspectives and recent findings. NIH conference. Ann Intern Med 1982, 97:740-754.
3. World Health Organization Evaluation of carcinogenic risk to humans. Schistosomes, liver flukes and Helicobacter pylori. IARC Monogr 1994, 61:45-119.
4. Khalil M. The History and progress of anti ankylostomiasis and anti-bilharziasis work. In Egypt, Part III Resumption Campaign 1919. Report of Public Health Laboratories in Government Records. Cairo; 1924.
5. El Khoby T., Galal N., Fenwick A. The USAID/Government Egypt's Schistosomiasis Research Project (SRP). Parasitol Today 1998, 14:92-96.
6. The World Bank. Project performance assessment report Arab Republic of Egypt national schistosomiasis control project. World Bank 2008, 80. <> [accessed 5.03.10]. http://www.wds.worldbank.org.
7. Young N.D., Jex A.R., Li B., Liu S., Yang L., Xiong Z., et al. Whole genome sequence of Schistosoma hematobium. Nat Genet 2012, 44(2):221-225.
8. Cancer Statistics at the National Cancer Institute, Cairo University. <>. http://www.nci.cu.edu.eg/lectures/Cancer_statistics2002-2007.pdf.
9. National Cancer Registry Program of Egypt. <>. http://www.cancerregistry.gov.eg/reports.aspx.
10. Mostafa M.H., Sheweita S.A., O'Connor P.J. Relationship between schistosomiasis and bladder cancer. Clin Microbiol Rev 1999, 12:97-111.
11. Rosin M.P., Anwar W.A., Ward A.J. Inflammation, chromosomal instability, and cancer: the schistosomiasis model. Cancer Res 1994, 54:1929s-1933s.
12. Rosin M.P., Saad el Din Zaki S., Ward A.J., Anwar W.A. Involvement of inflammatory reactions and elevated cell proliferation in the development of bladder cancer in schistosomiasis patients. Mutat Res 1994, 305:283-292.
13. Marletta M.A. Mammalian synthesis of nitrite, nitrate, nitric oxide, and N-nitrosating agents. Chem Res Toxicol 1988, 1:249-257.
14. Weitzman S.A., Stossel T.P. Mutation caused by human phagocytes. Science 1981, 212:546-547.
15. Weitberg A.B. Effect of combinations of antioxidants on phagocyte-induced sister-chromatid exchanges. Mutat Res 1989, 224:1-4.
16. Shacter E., Beecham E.J., Covey J.M., Kohn K.W., Potter M. Activated neutrophils induce prolonged DNA damage in neighboring cells. Carcinogenesis 1988, 9:2297-2304.
17. O'Brien P.J. Radical formation during the peroxidase catalyzed metabolism of carcinogens and xenobiotics: the reactivity of these radicals with GSH, DNA, and unsaturated lipid. Free Radic Biol Med 1988, 4:169-183.
18. Botelho M., Ferreira A.C., Oliveira M.J., Domingues A., Machado J.C., Da Costa J.M. Schistosoma hematobium total antigen indices increased proliferation, migration, and invasion and decreases apoptosis of normal epithelial cells. Int J Parasitol 2009, 39:1083-1091.
19. Botelho M.C., Oliveira P.A., Lopes C., Correia da Costa J.M., Machado J.C. Urothelial dysplasia and inflammation induced by Schistosoma hematobium total antigen instillation in mice normal urothelium. Urol Oncol 2011, 29(6):809-814.
20. Fadl-Elmula I., Kytola S., Leithy M.E., Abdel-Hameed M., Mandahl N., Elagib A., et al. Chromosomal aberrations in benign and malignant bilharzial - associated bladder lesions analyzed by genomic hybridization. BMC Cancer 2002, 22(2:5).
21. El-Rifai W., Kamel D., Larramendy M.L., Shoman S., Gad Y., Baithun S., et al. DNA copy number changes in Schistosoma-associated and non-Schistosoma-associated bladder cancer. Am J Pathol 2000, 156(3):871-878.
22. Khaled H.M., Aly M.S., Mokhtar N. Chromosomal aberrations in Cis and Ta bilharzial bladder cancer: a theory of pathogenesis. Urol Oncol 2004, 22(6):443-447.
23. Ishikawa J., Xu H.J., Hu S.X., Yandell D.W., Maeda S., Kamidono S., et al. Inactivation of the retinoblastoma gene in human bladder and renal cell carcinomas. Cancer Res 1991, 51:5736-5743.
24. Knowles M.A., Williamson M. Mutations of H-ras is infrequent in bladder cancer: confirmation by single-strand conformation polymorphism analysis, designed restriction fragment length polymorphism, and direct sequencing. Cancer Res 1993, 53:133-139.
25. Gad El Mawla N., El Bolkainy M.N., Khaled H.M. Bladder cancer in Africa: update. Sem Oncol 2001, 28(2):174-178.
26. Khaled H.M., Abdel Salam I.M., Abdel Gawad M., Metwally A., El Demerdash S., El Didi M., et al. Evaluation of the BTA tests for the detection of bilharzial related bladder cancer: the Cairo experience. Eur Urol 2001, 39:91-94.
27. Gutierrez M.I., Siraj A.K., Khaled H., Koon N., El-Rifai W., Bhatia K. CpG island methylation in Schistosoma and non-Schistosoma-associated bladder cancer. Mod Pathol 2004, 17(10):1268-1274.
28. Yang H., Yang K., Khafagi A., Tang Y., Carey T.E., Opipari A.W., et al. Sensitive detection of human papillomavirus in cervical, head/neck, and schistosomiasis-associated bladder malignancies. Proc Natl Acad Sci 2005, 24, 102(21):7683-7688.
29. Zarzour A.H., Selim M., Abd-Elsayed A.A., Hameed D.A., AbdelAziz M.A. Muscle invasive bladder cancer in Upper Egypt: the shift in risk factors and tumor characteristics. BMC Cancer 2008, 8(250).
30. Lamm D.L., Tori F.M. Bladder Cancer, CA. Cancer J Clin 1996, 46:93-112.
31. Gouda I., Mokhtar N., Bilal D., El-Bolkainy T., El-Bolkainy M.N. Bilharziasis and bladder cancer: a time trend analysis of 9843 patients. J Egypt Nat Cancer Inst 2007, 19(2):158-162.
32. Felix A.S., Soliman A.S., Khaled H., Zaghloul M.S., Banerjee M., El-Baradie M., et al. The changing pattern of bladder cancer in Egypt over the past 25years. Cancer Causes Control 2008, 19(4):421-429.
33. Mohktar N., Gouda I., Adel I. Malignant urinary system tumors. Cancer pathology registry 2007, Department of Pathology, National Cancer Institute, Cairo University, El Sheraaa for Advertising.
34. Ghonein M., EL Mekresh M.M., El Baz M.A., El-Attar I.A., Ashamallah A. Radical cystectomy for carcinoma of the bladder: critical evaluation of the result in 1026 cases. J Urol 1997, 158(2):393-399.
35. Khaled H., El Hattab O., Moneim D.A., Kassem H.A., Morsi A., Sherif G., et al. A prognostic index (bladder prognostic index) for bilharzial-related invasive bladder cancer. Urol Oncol 2005, 23(4):254-260.
36. Zaghloul M.S. Distant metastasis from bilharzial bladder cancer. Cancer 1996,15, 77(4):743-749.
37. Zaghloul M.S. Adjuvant and neoadjuvant radiotherapy for bladder cancer: revisited. Future Oncol 2010, 6(7):1177-1191.
38. Khaled H.M. Systemic management of bladder cancer in Egypt: revisited. J Egypt Nat Cancer Inst 2005, 17(3):127-131.
39. Abol-Enein H., El Makresh M., El Baz M. Neoadjuvant chemotherapy in the treatment of invasive transitional bladder cancer. A controlled, prospective randomized study. Br J Urol 1997, 79(Suppl 4):43.
40. Zaghloul MS, Khaled HM, Lotayef M, William H. Adjuvant chemoradiotherapy after radical cystectomy in advanced high risk bladder cancer patients: a prospective randomized trial. In: ASCO 42nd annual meeting. Orlando, FL, USA, Abstract; 2006. p. 4545.
41. Gad El-Mawla N., Hamza M.R., Zikri Z., El-Serafi M., El-Khodary A., Khaled H., et al. Chemotherapy in invasive carcinoma of the bladder, a review of phase II trials in Egypt. Acta Oncol 1989, 28(1):73-76.
42. Khaled H.M., Gad El-Mawla N., El-Said A., Hamza M.R., Gaafar R., El-Attar I., et al. Combination chemotherapy for advanced bilharzial bladder cancer. Ann Oncol 1996, 7:751-754.
43. Khaled H.M., Hamza M.R., Mansour O., Gaafar R., Zaghloul M.S. A phase II study of gemcitabine plus cisplatin chemotherapy in advanced bilharzial bladder Carcinoma. Eur J Cancer 2000, 36:s34-s37.
44. Khaled H., Emara M.E., Gaafar R.M., Mansour O., Abdel Warith A., Zaghloul M.S., et al. Primary chemotherapy with low-dose prolonged infusion gemcitabine and cisplatin in patients with bladder cancer: a Phase II trial. Urol Oncol 2008, 26(2):133-136.
45. Botelho M.C., RIBEIRO R., Vale N., Oliveira P., Mediro R., Lopes C., et al. Inactivation of estrogen receptor by Schistosoma hematobium total antigen in bladder urothelial cells. Oncol Rep 2012, 27(2):356-362.